frenolicin b has been researched along with cl 387785 in 1 studies
| Studies (frenolicin b) | Trials (frenolicin b) | Recent Studies (post-2010) (frenolicin b) | Studies (cl 387785) | Trials (cl 387785) | Recent Studies (post-2010) (cl 387785) |
|---|---|---|---|---|---|
| 18 | 0 | 9 | 34 | 0 | 14 |
| Protein | Taxonomy | frenolicin b (IC50) | cl 387785 (IC50) |
|---|---|---|---|
| Proto-oncogene tyrosine-protein kinase Src | Gallus gallus (chicken) | 0.001 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 0.0456 | |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 0.1952 | |
| Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (human) | 0.012 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 0.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barf, T; Kaptein, A | 1 |
1 review(s) available for frenolicin b and cl 387785
| Article | Year |
|---|---|
Irreversible protein kinase inhibitors: balancing the benefits and risks.
Topics: Animals; Cell Line; Humans; Protein Kinase Inhibitors; Protein Kinases; Risk; Structure-Activity Relationship; Time Factors | 2012 |